David Kirn
2020
In 2020, David Kirn earned a total compensation of $701.5K as Chief Executive Officer at 4D Molecular Therapeutics, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $237,344 |
|---|---|
| Salary | $451,189 |
| Other | $13,000 |
| Total | $701,533 |
Kirn received $451.2K in salary, accounting for 64% of the total pay in 2020.
Kirn also received $237.3K in non-equity incentive plan and $13K in other compensation.
Rankings
In 2020, David Kirn's compensation ranked 9,975th out of 13,090 executives tracked by ExecPay. In other words, Kirn earned more than 23.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,975 out of 13,090 | 24th |
Division Manufacturing | 4,291 out of 5,624 | 24th |
Major group Chemicals And Allied Products | 1,764 out of 2,257 | 22nd |
Industry group Drugs | 1,544 out of 1,957 | 21st |
Industry Biological Products, Except Diagnostic Substances | 351 out of 411 | 15th |
Source: SEC filing on April 6, 2021.
Kirn's colleagues
We found two more compensation records of executives who worked with David Kirn at 4D Molecular Therapeutics in 2020.
News
4D Molecular Therapeutics CEO David Kirn's 2023 pay jumps 213% to $10M
April 10, 2024
4D Molecular Therapeutics CEO David Kirn's 2022 pay falls 37% to $3.3M
April 12, 2023
4D Molecular Therapeutics CEO David Kirn's 2021 pay jumps 641% to $5.2M
April 13, 2022
4D Molecular Therapeutics Chief Medical Officer Robert Fishman receives $3.3M in 2020
April 6, 2021